4-101025858-G-T
Position:
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP4_StrongBP6_ModerateBS2
The NM_000944.5(PPP3CA):c.*7C>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0115 in 1,058,810 control chromosomes in the GnomAD database, including 121 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.0083 ( 14 hom., cov: 29)
Exomes 𝑓: 0.012 ( 107 hom. )
Consequence
PPP3CA
NM_000944.5 3_prime_UTR
NM_000944.5 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: 2.69
Genes affected
PPP3CA (HGNC:9314): (protein phosphatase 3 catalytic subunit alpha) Enables several functions, including ATPase binding activity; calmodulin binding activity; and calmodulin-dependent protein phosphatase activity. Involved in several processes, including calcineurin-NFAT signaling cascade; peptidyl-serine dephosphorylation; and response to calcium ion. Located in several cellular components, including cytosol; dendritic spine; and nucleoplasm. Part of calcineurin complex. Colocalizes with cytoplasmic side of plasma membrane. Implicated in developmental and epileptic encephalopathy 91. Biomarker of focal segmental glomerulosclerosis and schizophrenia. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -10 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.49).
BP6
Variant 4-101025858-G-T is Benign according to our data. Variant chr4-101025858-G-T is described in ClinVar as [Benign]. Clinvar id is 1695101.Status of the report is criteria_provided_single_submitter, 1 stars.
BS2
High AC in GnomAd4 at 1158 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
PPP3CA | NM_000944.5 | c.*7C>A | 3_prime_UTR_variant | 14/14 | ENST00000394854.8 | ||
PPP3CA | NM_001130691.2 | c.*7C>A | 3_prime_UTR_variant | 13/13 | |||
PPP3CA | NM_001130692.2 | c.*7C>A | 3_prime_UTR_variant | 12/12 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
PPP3CA | ENST00000394854.8 | c.*7C>A | 3_prime_UTR_variant | 14/14 | 1 | NM_000944.5 | P3 |
Frequencies
GnomAD3 genomes AF: 0.00829 AC: 1158AN: 139742Hom.: 14 Cov.: 29
GnomAD3 genomes
AF:
AC:
1158
AN:
139742
Hom.:
Cov.:
29
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0102 AC: 2017AN: 198388Hom.: 26 AF XY: 0.0100 AC XY: 1090AN XY: 108478
GnomAD3 exomes
AF:
AC:
2017
AN:
198388
Hom.:
AF XY:
AC XY:
1090
AN XY:
108478
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0120 AC: 11017AN: 919020Hom.: 107 Cov.: 26 AF XY: 0.0115 AC XY: 5360AN XY: 464856
GnomAD4 exome
AF:
AC:
11017
AN:
919020
Hom.:
Cov.:
26
AF XY:
AC XY:
5360
AN XY:
464856
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00828 AC: 1158AN: 139790Hom.: 14 Cov.: 29 AF XY: 0.00920 AC XY: 618AN XY: 67168
GnomAD4 genome
AF:
AC:
1158
AN:
139790
Hom.:
Cov.:
29
AF XY:
AC XY:
618
AN XY:
67168
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2
AN:
3476
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Aug 01, 2024 | PPP3CA: BS1, BS2 - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at